Cellebrite DI Ltd. CLBT
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | 18.56% | 18.37% | 20.48% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 18.56% | 18.37% | 20.48% | |
| Cost of Revenue | -- | 20.09% | 22.08% | 19.07% | |
| Gross Profit | -- | 18.28% | 17.68% | 20.75% | |
| SG&A Expenses | -- | 20.11% | 21.34% | 20.11% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 18.85% | 19.91% | 20.05% | |
| Operating Income | -- | 16.83% | 9.30% | 23.16% | |
| Income Before Tax | -- | 132.86% | 127.35% | -49.24% | |
| Income Tax Expenses | -- | 75.88% | -8.36% | -0.97% | |
| Earnings from Continuing Operations | -- | 127.68% | 124.09% | -46.08% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 127.68% | 124.09% | -46.08% | |
| EBIT | -- | 16.83% | 9.30% | 23.16% | |
| EBITDA | -- | 16.05% | 8.08% | 19.77% | |
| EPS Basic | -- | 123.12% | 120.63% | -44.24% | |
| Normalized Basic EPS | -- | 861.01% | 198.62% | 198.62% | |
| EPS Diluted | -- | 122.20% | 119.83% | -42.79% | |
| Normalized Diluted EPS | -- | 721.69% | 194.12% | 194.12% | |
| Average Basic Shares Outstanding | -- | 15.36% | 19.46% | 17.62% | |
| Average Diluted Shares Outstanding | -- | 17.34% | 24.59% | 20.10% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |